Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Ramparva Samajik Shaikshanik Seva Samiti
Street 1: At.Junna Post.Shikara Tq.Mukhed Dist.Nanded
Street 2:
City: Nanded
Province:
Post Code: 431715
Country: India
Phone: +919272161123
Organization Email: ramparva@gmail.com
Web Site:
Other Online Presence:

Focal Point Contact Information

Salutation: Dr.
First Name: Anand
Last Name: Taru
Title: Coordinator
Email: ramparva@gmail.com
Phone:  

Alternate Focal Point Contact Information

Salutation: Mr.
First Name: Sandeep
Last Name: Kadam
Title: Secretary
Email: ramparva@gmail.com
Phone:  

General Information

Board Constituency: Developing Country NGO
Is your organization legally registered in your country: Yes
If yes, please enter your registration number: MH 484
Organization Type - Primary: Non-Governmental Organization
Organization Type - Secondary: Other Non-Governmental Organization (NGO)
Organization Description:
1.Vision:
Realization of “Social Justice and Peace” for the poor and the marginalized children, youth and women through the process of empowerment.
2.Some 2 million new cases of TB yearly, India bears the highest burden of TB globally. It also has among the highest number of MDR-TB cases.
3.Involve all health care providers to increase the reach of TB services.
Ensure the rational use of drugs and diagnostics.
Provide access information and treatment for TB – women, children, tribal populations, communities living in geographically difficult areas and vulnerable groups, such as people co-infected with TB and HIV.
Outcome of the community Level meetings:
Awareness generated on TB.
Enhanced awareness on TB centres at the nearest locations
Increased referrals of TB cases
Motivate / Initiate cases on TB treatment
Decreased default cases.
Reduce myths and misconceptions on TB and its treatment
 
Do you know about the UNHLM declaration:

Specializations / Areas of Work

Advocacy
Civil Society and Community Engagement
Delivery of health services and care
Provision of drugs, diagnostics and commodities
Research and Development
Working on Community, Rights and Gender (CRG)
Working on Key Populations related to TB

Other Organization Information

Total number of staff in your organization: 11 - 25
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 1 - 5
 
How did you hear about the Stop TB Partnership: Internet search
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Involvement in Stop TB Working Groups
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
Involve all health care providers to increase the reach of TB services.
Ensure the rational use of drugs and diagnostics.
Provide access information and treatment for TB – women, children, tribal populations, communities living in geographically difficult areas and vulnerable groups, such as people co-infected with TB and HIV.
Outcome of the community Level meetings:
Awareness generated on TB.
Enhanced awareness on TB centres at the nearest locations
Increased referrals of TB cases
Motivate / Initiate cases on TB treatment
Decreased default cases.
Reduce myths and misconceptions on TB and its treatment
 

Geographical Reach

Which country is your headquarters located in: India
Which countries do you do operate in:
(This includes countries you are conducting activities in)
India

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
Pursue quality DOTS expansion and enhancement, by improving the case finding are cure through an effective patient-centred approach to reach all patients, especially the poor.
Address TB-HIV, MDR-TB and other challenges, by scaling up TB-HIV joint activities, DOTS Plus, and other relevant approaches.
Contribute to health system strengthening, by collaborating with other health programmes and general services
Involve all health care providers, public, nongovernmental and private, by scaling up approaches based on a public-private mix (PPM), to ensure adherence to the International Standards of TB care.
Engage people with TB, and affected communities to demand, and contribute to effective care. This will involve scaling-up of community TB care; creating demand thorugh context-specific advocacy, communication and social mobilization.
Enable and promote research for the development of new drugs, diagnostic and vaccines. Operational Research will also be needed to improve programme performance.

Drug-Resistant TB:
Good quality diagnosis. Good quality microscopy allows health workers to see the tubercle bacilli and is essential to identify the infectious patients who need treatment the most.
Good quality drugs. An uninterrupted supply of good quality anti-TB drugs must be available. In the RNTCP, a box of medications for the entire treatment is earmarked for every patient registered, ensuring the availability of the full course of treatment the moment the patient is initiated on treatment. Hence in DOTS, the treatment can never interrupt for lack of medicine.
Supervised treatment to ensure the right treatment, given in the right way. The RNTCP uses the best anti-TB medications available. But unless treatment is made convenient for patients, it will fail. This is why the heart of the DOTS programme is "directly observed treatment" in which a health worker, or another trained person who is not a family member, watches as the patient swallows the anti-TB medicines in their presence.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: August 4, 2013
Last updated: October 1, 2019